Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $10.5 Million - $12.8 Million
88,000 Added 72.37%
209,600 $25 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $10.1 Million - $12.1 Million
82,500 Added 211.0%
121,600 $17.4 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $3.99 Million - $5.31 Million
39,100 New
39,100 $5.02 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $11 Million - $12.2 Million
70,500 New
70,500 $11.4 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $245B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.